Article Correctness Is Author's Responsibility: SU2C launches ‘cancer interception’ initiative to detect & treat cancer at earliest stages

(Entertainment Industry Foundation) Stand Up To Cancer (SU2C), the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, have awarded a total of $16.6 million to four teams of top researchers to carry out an attack on cancers of the lung and pancreas using a radical new approach of "interception" of cancers at very early stages when they can be more successfully treated, even catching precancerous cells and blocking them from turning into cancer cells.